Table 3. Risk factors of kidney failure.
| Univariate | Age- & sex-adjusted | |||||
|---|---|---|---|---|---|---|
| HR | 95% CI | p value | HR | 95% CI | p value | |
| Lab data | ||||||
| Creatinine | 1.43 | [1.25–1.62] | <0.001** | 1.45 | [1.27–1.66] | <0.001** |
| Hemoglobin | 0.91 | [0.81–1.02] | 0.116 | 0.87 | [0.77–0.99] | 0.039* |
| CRP | 0.98 | [0.94–1.02] | 0.237 | 0.98 | [0.94–1.01] | 0.208 |
| Platelet | 1.00 | [1.00–1.00] | 0.154 | 1.00 | [1.00–1.00] | 0.124 |
| WBC | 1.00 | [1.00–1.00] | 0.893 | 1.00 | [1.00–1.00] | 0.856 |
| Total bilirubin | 1.05 | [0.96–1.16] | 0.298 | 1.07 | [0.97–1.18] | 0.172 |
| Albumin | 0.71 | [0.46–1.10] | 0.128 | 0.72 | [0.46–1.13] | 0.151 |
| Galactomannan test | ||||||
| Blood-first | 1.29 | [1.13–1.48] | <0.001** | 1.27 | [1.11–1.46] | 0.001** |
| Blood-max | 1.14 | [1.02–1.28] | 0.026* | 1.13 | [1.01–1.27] | 0.037* |
| BAL-first | 1.17 | [1.02–1.33] | 0.025* | 1.18 | [1.03–1.35] | 0.018* |
| BAL-max | 1.16 | [1.02–1.33] | 0.028* | 1.17 | [1.02–1.34] | 0.021* |
| Comorbidity | ||||||
| COPD | 1.13 | [0.48–2.64] | 0.786 | 0.99 | [0.40–2.46] | 0.980 |
| Asthma | 1.40 | [0.66–2.99] | 0.380 | 1.36 | [0.63–2.93] | 0.438 |
| Liver cirrhosis | 2.51 | [0.78–8.10] | 0.125 | 2.67 | [0.81–8.82] | 0.107 |
| DM | 2.24 | [1.23–4.06] | 0.008** | 2.07 | [1.12–3.82] | 0.021* |
| Hematological disease | 0.43 | [0.25–0.77] | 0.004** | 0.44 | [0.25–0.79] | 0.006** |
| Solid organ malignancy | 0.91 | [0.44–1.87] | 0.792 | 0.82 | [0.39–1.72] | 0.597 |
| Liver or kidney transplant | 3.07 | [1.30–7.27] | 0.011* | 3.45 | [1.37–8.65] | 0.008** |
| IPA groups | ||||||
| Possible IPA | Reference | Reference | ||||
| Probable IPA | 2.18 | [1.13–4.21] | 0.020* | 2.17 | [1.12–4.20] | 0.021* |
| Proven IPA | 0.51 | [0.11–2.23] | 0.368 | 0.45 | [0.10–2.01] | 0.295 |
| Putative IPA | 3.96 | [1.73–9.05] | 0.001** | 3.41 | [1.45–8.01] | 0.005** |
Notes:
Cox proportional hazard regression.
p < 0.05.
p < 0.01.
CRP, C-reactive protein; WBC, white blood cell; BAL, bronchial alveolar lavage; COPD, chronic obstructive pulmonary disease; DM, diabetes mellitus; IPA, invasive pulmonary aspergillosis.